Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases

Relevance of photobiomodulation technique in AD treatment

13th Clinical Trials on Alzheimer’s Disease (CTAD) 2020, virtual conference

Jacques Touchon

Share this article